Industries > Pharma > North America Molecular Diagnostics Market Report 2020-2030

North America Molecular Diagnostics Market Report 2020-2030

Revenue Prospects by Test (Point of Care, Self-test or Over the Counter (OTC), Central laboratories), by Product (Instruments, Reagents, Others), Technology (Polymerase Chain Reaction (Multiplex PCR, Other PCR), Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), In Situ Hybridization, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others), Application (Cardiovascular Disease, Genetic Testing (Newborn Screening, Predictive and Presymptomatic Testing, Other Genetic Testing), Infectious Diseases (Clostridium Difficile, Candida, Clostridium Difficile, Chlamydia, Flu, Gastrointestinal Panel Testing, Gonorrhea, HIV, Hepatitis B, Hepatitis C, Meningitis, Methicillin-resistant Staphylococcus Aureus, Respiratory Syncytial Virus, Tuberculosis and Drug-resistant, Others), Microbiology, Neurological Diseases, Oncology (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer, Other Cancer) Pharmacogenomics, Others) and Geography

PAGES: 199
PRODUCT CODE: PHA0617
SUBMARKET: Diagnostics

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0617 Categories: , Tags: ,

Molecular Diagnostics– our new study reveals trends, R&D progress, and predicted revenues
Where is the Molecular Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 150+ page report provides 13 tables, 25 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Molecular Diagnostics market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the North American market and submarkets
Along with revenue prediction for the overall North American market, there are 4 segmentations of the North American Molecular Diagnostics market, with forecasts for 3 Tests, 3 Products, 7 Technologies, 8 Applications, each forecasted at a regional level.

North America Molecular Diagnostics Market by Test
– Point of Care
– Self-test or Over the Counter (OTC)
– Central laboratories

North America Molecular Diagnostics Market by Product
– Instruments
– Reagents
– Others

North America Molecular Diagnostics Market by Technology
– Polymerase Chain Reaction (PCR)
– Polymerase Chain Reaction (Multiplex PCR
– Other PCR
– Chips and microarrays
– Isothermal Nucleic Acid Amplification Technology (INAAT)
– In Situ Hybridization
– Mass Spectrometry
– Sequencing
– Transcription Mediated Amplification (TMA)
– Others

North America Molecular Diagnostics Market by Application
– Cardiovascular Disease
– Genetic Testing
– Newborn Screening
– Predictive and Presymptomatic Testing
– Other Genetic Testing
– Infectious Diseases
– Clostridium difficile
– Candida
– Clostridium difficile
– Chlamydia
– Flu
– Gastrointestinal Panel Testing
– Gonorrhea
– HIV
– Hepatitis B
– Hepatitis C
– Meningitis
– Methicillin-resistant Staphylococcus Aureus
– Respiratory Syncytial Virus
– Tuberculosis and drug-resistant
– Others
– Microbiology
– Neurological Diseases
– Oncology
– Breast Cancer
– Prostate Cancer
– Colorectal Cancer
– Cervical Cancer
– Kidney Cancer
– Liver Cancer
– Blood Cancer
– Lung Cancer
– Other Cancer
– Pharmacogenomics
– Other Applications

In addition to the revenue predictions for the overall North American market and segments, you will also find revenue forecasts for following markets:

– North America:
– U.S.
– Canada

The report also includes profiles and for some of the leading companies in the Molecular Diagnostics market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall North American revenue for Molecular Diagnostics Market will surpass $8 billion in 2025, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Molecular Diagnostics Market report helps you
In summary, our 150+ page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 4 segmentations of the Molecular Diagnostics market, with forecasts for 3 Tests, 3 Products, 7 Technologies, 8 Applications, each forecasted at a regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

– Prospects for established firms and those seeking to enter the market– including company profiles for xx of the major companies involved in the Molecular Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Molecular Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today The Molecular Diagnostics Market Forecast 2020-2030: Revenue Prospects by Test (Point of Care , Self-test or Over the Counter (OTC), Central laboratories), Product (Instruments, Reagents, Others), Technology {Polymerase Chain Reaction (Multiplex PCR, Other PCR), Chips and microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), In Situ Hybridization, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others}, Application {Cardiovascular Disease, Genetic Testing (Newborn Screening, Predictive and Presymptomatic Testing, Other Genetic Testing), Infectious Diseases (Clostridium difficile, Candida, Clostridium difficile, Chlamydia, Flu, Gastrointestinal Panel Testing, Gonorrhea, HIV, Hepatitis B, Hepatitis C, Meningitis, Methicillin-resistant Staphylococcus Aureus, Respiratory Syncytial Virus, Tuberculosis and drug-resistant, Others), Microbiology, Neurological Diseases, Oncology (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer, Other Cancer) Pharmacogenomics, Others}, and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for North America Molecular Diagnostics Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for North America Molecular Diagnostics Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category